View in EDS

Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer—central evaluation of FIRE-3.

Saved in:
Bibliographic Details
Title: Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer—central evaluation of FIRE-3.
Authors: Modest, D.P.1,2 dominik.modest@med.uni-muenchen.de, Denecke, T.3, Pratschke, J.4, Ricard, I.5, Lang, H.6, Bemelmans, M.7, Becker, T.8, Rentsch, M.9, Seehofer, D.10, Bruns, C.J.11, Gebauer, B.3, Modest, H.I.12, Held, S.13, Folprecht, G.14, Heinemann, V.1,2, Neumann, U.P.7,15
Source: European Journal of Cancer. Jan2018, Vol. 88, p77-86. 10p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first